SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is a major talking point as investors eagerly await its earnings report amid intense debate over the semiconductor sector's recent volatility. The community is sharply divided, with many bulls citing unprecedented memory demand and attractive valuation due to AI tailwinds. However, others anticipate a potential post-earnings dip similar to other AI-related stocks that recently pulled back despite strong reports, making its market reaction a key focus.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group (GRRR) is trending amidst significant community discussion surrounding its recent stock performance, which many attribute to a broader market downturn impacting AI-related assets. Investors are actively debating the impact of a lawsuit alleging stock manipulation and a recent "Strong Buy" analyst upgrade, contrasted with ongoing concerns about the company's valuation relative to its reported substantial contracts. The conversation highlights a tension between the company's operational achievements and the market's current perception of its trajectory in the AI infrastructure sector.

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

Processa Pharmaceuticals is trending due to positive preliminary Phase 2 data for its metastatic breast cancer treatment, showing enhanced efficacy potential with comparable safety. This news, combined with a recent reverse stock split resulting in a very low float, has ignited intense speculative trading and numerous circuit breaker halts. The community is actively debating the potential for a significant squeeze amidst high volatility and discussions about overcoming short selling pressure.

Mega Fortune Co., Ltd. operates as an investment holding company. It specializes in delivering comprehensive IoT solutions and services across various industries. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune Company Limited (MGRT), a recent Hong Kong-based IoT IPO, is experiencing intense speculative interest driven by its low float and reported insider lock-up, drawing comparisons to other volatile Asian listings. The stock is seeing rapid price swings and frequent trading halts, prompting community discussions around its potential for significant short-term gains or swift corrections. Traders are closely watching key price levels as retail attention focuses on this high-risk, high-reward momentum play.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy (BE) is attracting intense debate as it navigates significant market volatility, influenced by the emergence of new competition in the fuel cell sector and a broader re-evaluation of high-growth AI infrastructure stocks. Community sentiment is sharply divided, with some investors concerned about steep declines and perceived institutional manipulation, while others emphasize BE's strong fundamentals and pivotal role in meeting the escalating energy demands of AI data centers, viewing current price action as a strategic buying opportunity. This polarization fuels active discussion around the stock's immediate future amid its crucial position in the evolving clean power landscape.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following news of its expanded Korea Battery Alliance and a Nokia partnership, significantly boosting its global production capacity for high-energy-density batteries. The community is also buzzing about a potential Amazon deal, while many investors view current price dips as a buying opportunity, confident in the company's strong fundamentals and long-term potential despite broader market volatility affecting growth stocks. This conviction underscores a belief in its leadership in the electric aviation and drone sectors.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as reports suggest potential multi-billion dollar investment talks with OpenAI, which could involve the AI company utilizing Amazon's Trainium chips, bolstering AWS's AI strategy. While this news excites some investors about Amazon's long-term potential and AI catalysts, many in the community express frustration over the stock's perceived stagnant performance despite strong underlying fundamentals. There is active discussion that Amazon may be undervalued or oversold compared to other tech leaders, despite its integral role in e-commerce and cloud.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to conflicting reports surrounding a significant data center financing deal, with initial news suggesting a key partner withdrew funding while Oracle maintains the project is on schedule with a new backer. This uncertainty fuels intense community debate over the company's substantial debt and ambitious AI infrastructure plans. The situation is seen by some as a potential "AI bubble" indicator, contributing to broader tech sector weakness.

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

Medline Inc - Ordinary Shares - Class A

Medline Inc.

Medline is trending following its significant market debut, hailed as 2025's largest IPO, which saw its stock soar immediately. The community is actively discussing its long-term potential as an essential medical supplier, with many anticipating substantial gains, while others express frustration over limited IPO allocations and highlight the company's considerable debt.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amidst new Phase 2 data from Structure Therapeutics and Phase 3 results from Eli Lilly's Retatrutide, which are intensifying discussion around the obesity drug market. The community is sharply divided, with bulls touting VKTX's 'best-in-class' efficacy and superior tolerability compared to competitors, while a vocal segment criticizes management for perceived missteps and slow movement on partnerships. This dynamic positions VKTX as a key player in a rapidly evolving, yet highly competitive, GLP-1 and GIP agonist landscape, generating significant debate over its current valuation and future trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
